ArticleOncotarget2023

Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.

Fiorella Vanderhoeven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.